Effects of subcutaneous, low-dose glucagon on insulin-induced mild hypoglycaemia in patients with insulin pump treated type 1 diabetes.
about
Cross-Validation of a Glucose-Insulin-Glucagon Pharmacodynamics Model for Simulation Using Data From Patients With Type 1 Diabetes.Glucagon in artificial pancreas systems: Potential benefits and safety profile of future chronic use.Practical Approaches to Diagnosing, Treating and Preventing Hypoglycemia in Diabetes.Design and Clinical Evaluation of a Novel Low-Glucose Prediction Algorithm with Mini-Dose Stable Glucagon Delivery in Post-Bariatric Hypoglycemia.Relationship between Optimum Mini-doses of Glucagon and Insulin Levels when Treating Mild Hypoglycaemia in Patients with Type 1 Diabetes - A Simulation Study.
P2860
Effects of subcutaneous, low-dose glucagon on insulin-induced mild hypoglycaemia in patients with insulin pump treated type 1 diabetes.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Effects of subcutaneous, low-d ...... pump treated type 1 diabetes.
@en
Effects of subcutaneous, low-d ...... pump treated type 1 diabetes.
@nl
type
label
Effects of subcutaneous, low-d ...... pump treated type 1 diabetes.
@en
Effects of subcutaneous, low-d ...... pump treated type 1 diabetes.
@nl
prefLabel
Effects of subcutaneous, low-d ...... pump treated type 1 diabetes.
@en
Effects of subcutaneous, low-d ...... pump treated type 1 diabetes.
@nl
P2860
P50
P921
P356
P1476
Effects of subcutaneous, low-d ...... n pump treated type 1 diabetes
@en
P2093
P2860
P304
P356
10.1111/DOM.12627
P577
2016-02-09T00:00:00Z